Market-Moving News for October 17th
Portfolio Pulse from ryanfaloona@benzinga.com
Aegis Capital Corp. acted as Exclusive Placement Agent on a $5.0 Million Private Placement for SciSparc Ltd. (NASDAQ:SPRC). Gilead Sciences and Assembly Biosciences announced a 12-year partnership for antiviral therapies, with Assembly Bio to receive $100M upfront payment. Wyndham Hotels & Resorts shares are trading higher after Choice Hotels proposed to acquire the company for $90.00 per share.
October 17, 2023 | 12:42 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Assembly Biosciences has entered into a 12-year partnership with Gilead Sciences for antiviral therapies, receiving a $100M upfront payment.
The partnership with Gilead Sciences and the upfront payment of $100M will provide Assembly Biosciences with significant resources for research and development. This is likely to have a positive impact on the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
SciSparc Ltd. received a $5.0 Million Private Placement from Aegis Capital Corp.
The private placement will provide SciSparc with additional capital, which could be used for growth and expansion. This is likely to have a positive impact on the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Wyndham Hotels & Resorts shares are trading higher after Choice Hotels proposed to acquire the company for $90.00 per share.
The acquisition proposal from Choice Hotels at $90.00 per share is likely to have a positive impact on Wyndham Hotels & Resorts' stock price in the short term as it represents a premium on the current trading price.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100